Clinical Nuclear Medicine

Skip Navigation LinksHome > September 2013 - Volume 38 - Issue 9 > Portal Shunt Scintigraphy (PSS) in the Evaluation of Patient...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31829a0164
Interesting Images

Portal Shunt Scintigraphy (PSS) in the Evaluation of Patients Suspected of Hereditary Hemorrhagic Telangiectasia

Nozawa, Asae MD; Miller, Frank J. MD; Rivandi, Ali Hosseini MD; Hoh, Carl K. MD

Collapse Box


Abstract: Vascular malformations of the liver in hereditary hemorrhagic telangiectasia may develop high output cardiac failure. Currently, the treatment for refractory hepatic vascular shunts includes hepatic artery embolization. However, hepatic or biliary necrosis may occur if inadequate portal blood flow supplies the liver. In this study, we applied noninvasive portal shunt scintigraphy to determine the portal shunt index for their evaluation. We present a case of the patient with a high PSI value and another case with a normal PSI value (<10%).

© 2013 by Lippincott Williams & Wilkins


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.